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Abstract
Background and purpose: Patients with internal carotid
artery (ICA) occlusion can demonstrate impaired cere-
bral  vascular  reserve  (CvR).  the  detection  of  CvR
using single photon emission Ct (SPECt) is nowa-
days widely accepted as a predictor in the diagnostic
pathway in patients considered for cerebral revascular-
ization.  Recently  perfusion  Ct  (PCt)  gained  widely
acceptance in stroke imaging. the present study was
aimed at comparing the results of perfusion Ct (PCt)
and 99mtc-HMPAo SPECt with acetazolamide chal-
lenge in patients with ICA occlusion.
Methods: 13 patients were included in the prospective
evaluation.  both  PCt  and  99mtc-HMPAo  SPECt
were performed before and after the administration of
acetazolamide. In detail, regional cerebral blood flow
(rCbf), regional cerebral blood volume (rCbv), adapt-
ed time to peak (tmax) and mean transit times (Mtt)
were compared with SPECt data.
Results: 99mtc-HMPAo SPECt demonstrated an im-
pairment of CvR in six patients. A preserved CvR
was  present  in  seven  patients.  All  patients  with  im-
paired  CvR  proven  by  SPECt  had  a  delayed  Mtt
(mean +2.98 s) and a delayed tmax (mean + 5.9 s),
(both p <0.005 compared with the non occluded side).
66%  of  patients  with  impaired  CvR  in  SPECt
showed  a  complete  correlation  of  tmax  measure-
ments  in  PCt  with  a  high  positive  predictive  value
(PPv: 88.8%).
Conclusion:  the  prospective  study  demonstrated  a
highly significant correlation of perfusion parameters
as detected by 99mtc-HMPAo SPECt and the tmax
as detected by PCt in patients with ICA occlusion.
therefore this easy-to-perform technique seems to be
an  adequate  method  for  the  evaluation  of  cerebral
perfusion in patients with ICA occlusion. 
Key  words: cerebral  vascular  reserve,  perfusion  Ct,
SPECt, internal carotid artery occlusion
IntRoduCtIon
Patients suffering from internal carotid artery (ICA)
occlusive disease can show a remarkable but individu-
ally variable risk of subsequent stroke. the annual risk
of stroke was estimated at 5.5% per year and accentu-
ated in patients with additional compromised cerebral
blood flow [1, 21]. therefore, besides clinical symp-
toms the impairment of the cerebral vascular reserve
(CvR),  which  reflects  the  capacity  to  maintain  ade-
quate blood flow in the face of decreased perfusion
pressure, has been identified as the major predictive
indicator for the risk of subsequent cerebral infarction
[1]. Since improvement of CvR can be achieved by
extra-intracranial (EC-IC) bypass surgery, it is impor-
tant to identify patients with perfusion impairment [2].
In  recent  years  several  techniques  have  been  estab-
lished  to  determine  CvR  comprising  single  photon
emission  computed  tomography  (SPECt)  [3],  tran-
scranial  doppler  (tCd)  ultrasound  [4],  perfusion
magnetic  resonance  imaging  (MRI)  [5-7],  positron
emission tomography (PEt) [8] and Xenon computed
tomography (Ct) [9]. nowadays SPECt analysis with
and  without  acetazolamide  (diamoxﾮ)  challenge  is
widely  regarded  as  gold  standard  in  the  diagnostic
pathway of patients with ICA occlusive disease and as-
sumed reduction of CvR. nonetheless, this examina-
tion has some disadvantages: first, due to tracer kinet-
ics it has to be performed on two days [14]. Second,
the analysis of the examination must be regarded as
semiquantitative  [6].  finally,  SPECt  provides  less
morphological information compared to MRI and to
regular Ct. the goal of the present study was to cor-
relate  perfusion  Ct  (PCt)  examinations  in  patients
with  ICA  occlusion  with  99mtc-HMPAo  SPECt  in
the evaluation of the cerebral CvR. to the best of our
knowledge a comparison of PCt and 99mtc-HMPAo
SPECt as presented in the study has hereby been per-
formed for the first time.
MEtHodS
PAtIEnt PoPulAtIon
Patients  suffering  from  symptomatic  arteriosclerotic
ICA occlusion and Moyamoya disease considered for
cerebral  revascularization  were  included  in  this
prospective single center study. Criteria for exclusion
were age under 18 years and a time interval between
PCt and 99mtc-HMPAo SPECt of longer than one
week. All patients had given informed consent.
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PCt  was  performed  using  a  multislice  Ct  Scanner
(volume Zoom, Siemens Erlangen/Germany, 80,0 kv,
120 mAs, 1 scan per second, over-all duration 35 s).
Patients were examined before and after acetazolamide
application (diamoxﾮ, 1000 mg i.v. over 2 min) the
same  day.  for  each  examination  patients  received  a
single  bolus  of  30  ml  contrast  agent  intravenously
(400 mg iodine/ml) equalizing a total iodine dose of
12 g. two slices with a slice thickness of 10 mm repre-
senting all three supratentorial vascular territories were
obtained. Raw data was transferred to a workstation
for further processing. Analysis comprising determina-
tion  of  mean  transit  time  (Mtt),  regional  cerebral
blood  flow  (rCbf),  regional  cerebral  blood  volume
(rCbv) and adapted time to peak (tmax) was carried
out  by  StRoKEtool-Ct  software  (version  2.0)
[10]. Compared to time to peak (ttP)-based measure-
ments tmax analysis allows minimizing the influence
of  extracerebral  conditions  such  as  circulation  time
[11]. Perfusion maps were further evaluated by use of
the computer software Angiotux Ct 2d [11] as previ-
ously described. for each hemisphere the mean values
of all four perfusion parameters in 18 overlapping de-
fined cortical segments (equalizing sections of 10ﾰ in-
tersection 2ﾰ) were determined. All segments were re-
lated to vascular territories: An occipital 30ﾰ segment
corresponds to the vascular territory of the posterior
cerebral artery, the adjacent 20ﾰ section to the posteri-
or  border  zone.  the  following  90ﾰ  segment  corre-
spond to the vascular territory of the middle cerebral
artery, 20ﾰ to the anterior border zone and the vascular
territory  of  the  anterior  cerebral  artery  each.  data
were  displayed  as  a  so-called  angle  plot  with  the
anatomical  localization  on  the  x  coordinate  and  the
perfusion parameters on the y coordinate and as mean
values of each cerebral hemisphere. the resulting dia-
gram allowed comparing perfusion parameters before
and  after  acetazolamide  stress.  CvR  calculation  was
carried out in two different ways: on the one hand on
the basis of rCbf data by use of the following formu-
la:  increase (%) = [(post-rCbf)-(pre-rCbf)]/(pre-
rCbf) x 100% whereas pre- and post-data refer to ac-
etazolamide  administration  [6].  A  difference  in  Cbf
between the occluded and non-occluded side of more
than 10% was defined as impaired CvR (according to
SPECt evaluations). on the other hand CvR estima-
tion was performed on the basis of delayed Mtt and
tmax. An increasing fraction of tmax and Mtt-val-
ues above a threshold of 3.5 s after acetazolamide in-
dicated depletion of CvR.
99mtC-HMPAo SPECt IMAGInG PRotoCol
All  patients  were  examined  with  the  identical  2-day
protocol with a maximum of one day between the two
examinations.Measurementof brainperfusionwas per  -
formed using stabilized exametazime (99mtc-HMPAo)
and SPECt. Image acquisition was initiated 20 min af-
ter injection of about 536 Mbq (range 500-670 Mbq)
stabilized  exametazime.  Acetazolamide  was  intra-
venously administered over 2 minutes during the stress
examination.  15  min  after  acetazolamide  infusion
99mtc-HMPAo was slowly injected. Patients were ex-
amined  in  a  supine  position  with  the  head  in  head
holders. for image acquisition, a Philips Prism 2000
XP  double-head  gamma  camera  (Marconi  plc,  lon-
don, England) was used. further evaluation was car-
ried out once the data had been transferred to a work-
station. Analysis of all studies was carried out by visu-
al interpretation and by comparison of RoIs in both
hemispheres. Impairment of CvR in 99mtc-HMPAo
SPECt imaging was defined as a rCbf restriction of
more than 10% in the occluded side compared to the
non-occluded side. In reverse a difference in rCbf less
than 10 % was defined as preserved CvR [6].
StAtIStICAl AnAlySIS
Statistical analysis comparing the PCt data (occluded
vs.  non  occluded  side)  was  performed  by  use  of  a
wilcoxon rank-sum test. this test was also applied to
compare  the  99mtc-HMPAo  SPECt  data  with  the
PCt  (SPSS,  version  16.0.1,  Chicago).  the  positive
predictive  value  (PPv)  was  calculated  using  the 
formula: number of right positive values/ (number of
right-positive  values  +  number  of  wrong-positive 
values).
RESultS
PAtIEntS
13  patients  (five  males  and  eight  females)  aged  be-
tween 18 and 69 years (average age: 50.3 years) were
included in the evaluation. In all patients we received
comparable examinations (7 before and 6 after bypass
surgery). A total of 13 parallel examinations were per-
formed. Symptomatic unilateral ICA occlusion (8 pa-
tients; 3 right-sided and 5 left-sided), Moyamoya dis-
ease  (4  patients)  and  symptomatic  unilateral
ICA/MCA occlusion (1 patient) were enclosed. All pa-
tients  had  symptoms  of  cerebrovascular  or  carotid
artery  disease  before  performing  an  EC-IC  bypass.
one  patient  presented  in  our  clinic  after  bypass
surgery for a check-up. 7 patients suffered from gener-
al arterial occlusive disease. other cerebrovascular risk
factors  (arterial  hypertension,  hypercholesterolemia
and diabetes mellitus) were present in 8 patients. one
patient displayed a cerebral aneurysm: a unilateral an-
terior cerebral artery (ACA) aneurysm.
11  EC-IC  bypass  surgeries  were  performed.  one
patient  underwent  EC-IC  bypass  surgery  on  both
symptomatic sides with a time lag of three months.
five high-flow bypass surgeries and one medium-flow
bypass surgery with autogenetic radial artery graft, one
barrel  EC-IC  bypass  surgery  (parietal  and  frontal
branches of the superficial temporal artery) and four
standard  EC-IC  bypass  surgeries  were  completed  in
our  department.  In  all  patients  a  preoperative  and
postoperative  study  including  cerebral  angiography,
Ct,  MRI  (preoperative)  and  a  perfusion  imaging 
with and without stress simulation was performed. In
7  patients  we  received  comparable  examinations
(99mtc-HMPAo SPECt/ PCt) before and in 6 pa-
tients after bypass surgery. PCt and  99mtc-HMPAo
SPECt  were  usually  performed  within  4  days.  Pa-
tients’ data are summarized in table 1.
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An impairment of CvR was found by 99mtc-HMPAo
SPECt in six analyses whereas a preservation of CvR
was present in seven examinations. table 2 gives you
an overview over the examined patients in detail.
RCbf And rCbv RESultS
four patients with unilateral ICA occlusion showed a
decrease of rCbf in the PCt analysis on the occluded
side without significant difference to the non-occluded
side. one patient with unilateral ICA occlusion and re-
duced  CvR  in  99mtc-HMPAo  SPECt  displayed  a
49.6% increase of rCbf in PCt on the occluded side
(an  asymptomatic  stenosis  on  the  contralateral  side
was known). one patient with ICA occlusion of the
right side and asymptomatic carotid artery stenosis on
the left and preserved CvR in 99mtc-HMPAo SPECt
presented with a 202.2% decrement in rCbf on the
right  hemisphere  in  comparison  to  the  contralateral
side. 
In the subgroup of Moyamoya disease one patient
displayed an impairment of CvR in SPECt. this pa-
tient  presented  with  an  incremented  rCbf  of  the
symptomatic  hemisphere,  without  statistical  signifi-
cance in comparison to the contra lateral side. two pa-
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Fig. 2. Patient no. 1 (further details see table 1) with left sided ICA occlusion. Significant impairment of CvR can be detected
by 99mtc-HMPAo SPECt. a-e show 99mtc-HMPAo SPECt and PCt images before acetazolamide administration. f-j illus-
trates 99mtc-HMPAo SPECt and PCt images after acetazolamide administration. the 99mtc-HMPAo SPECt images (a, f)
demonstrate impairment in the left parietal and occipital lobes. tmax (b, g) and Mtt (c, h) measurements show a delay in the
parietooccipital territories after acetazolamide (g, h). no significant difference before and after acetazolamide administration can
be detected in the perfusion measurement regarding Cbv (d, i) and Cbf (e, j).
Fig.  1.  brain  map  devided  into  36  segments  and  the  six
analysed vascular terretories.
Table  2. Impaired  and  preserved  CvR  in  99mtc-HMPAo
SPECt analyses.
Impaired CvR in SPECt Preserved CvR in SPECt
- unilateral ICA occlusion 1 - unilateral ICA occlusion 3
- Moyamoya disease 1 - Moyamoya disease 3
- bilateral ICA occlusion * 3 - bilateral ICA occlusion * 1
- ICA/MCA occlusion 1 - ICA/MCA occlusion -
* one symptomatic hemisphere
3) Eicker##_Umbruchvorlage  12.10.11  12:53  Seite 487tients  with  Moyamoya  disease  and  with  preserved
CvR  in  99mtc-HMPAo SPECt  showed  completely
different results of rCbf: one presented with an in-
crease by 86% and another with a decrease by 60.6%
(comparison of the occluded and the less or non-oc-
cluded  side).  the  patient  with  ICA/MCA  occlusion
presented with an incremented rCbf, which was not
statistically significant compared to the non-occluded
side. 
RCbv  measurements  also  showed  heterogeneous
results similar to the rCbf measurements. 
CvR calculation on the basis of rCbf provided the
following results:
five  of  the  six  patients  with  impaired  CvR  in
99mtc-HMPAo SPECt also had impaired CvR in the
PCt  studies.  one  patient  without  correlation  (pre-
served CvR in PCt regarding rCbf) showed sympto-
matic  ICA/MCA  occlusion.  five  patients  with  pre-
served CvR in 99mtc-HMPAo SPECt imaging were
detected in the rCbf imaging with an impaired CvR
(two patients with Moyamoya, one with bilateral ICA
occlusion and two patients with unilateral ICA occlu-
sion). therefore, no significant correlation of SPECt
and PCt data could be detected in the group with pre-
served CvR.
Mtt And tmax RESultS
An increasing fraction of Mtt-values above a thresh-
old of 3.5 s after acetazolamide was defined as im-
paired CvR.
According  to  our  definition,  a  CvR  was  seen  as
preserved  if  more  than  50%  of  regions  of  interest
(RoIs) were below this critical value. for better com-
parison with 99mtc-HMPAo SPECt imaging, the 36
cortical segments analyzed in PCt were pooled to six
vascular territories; the posterior cerebral artery (PCA)
territory, the MCA territory and the ACA territory bi-
lateral. As a result, a significant correlation between
tmax and 99mtc-HMPAo SPECt was detected. this
correlation  was  not  evident  in  the  comparison  of
rCbf  and  99mtc-HMPAo SPECt.  Mtt  and  tmax
measurement  yielded  the  following  results.  In  the
overall patient cohort, Mtt was delayed by 3.8 s (Sd:
2.7) and tmax was delayed by 11.92 s (Sd: 7.3) on the
occluded  side  (mean  values).  Patients  with  impaired
CvR proven by 99mtc-HMPAo SPECt showed a de-
layed  Mtt  (mean  +2.98  s;  Sd:  2.7)  and  a  delayed
tmax (mean + 5.9 s; Sd: 4.1). these findings were
statistically significant with regard to the frontal and
parietal vascular territories, i.e. MCA and ACA (all p<
0.005 compared with the non occluded side). Howev-
er, in the posterior vascular territory we found differ-
ences that had no statistical significance.
According to our definition only tmax values had
an increasing fraction above a threshold of 3.5 s after
acetazolamide in all subgroups witch indicated deple-
tion of CvR. 
these  tmax  measurements  and  SPECt  data
showed a positive correlation. 66% of patients with
impaired CvR in SPECt showed a complete consis-
tency in tmax measurements in the analyzed six terri-
tories in PCt (p=1). In six of the remaining patients
we found an absolute correlation in five of six territo-
ries. only one patient had a positive matching just in
three of six territories. the precision rate for tmax
was high (88.8%).
dISCuSSIon
A number of different techniques to determine cere-
bral perfusion in patients with occlusive carotid artery
disease have been described. SPECt, tCd ultrasound,
perfusion MRI, PEt, Xenon Ct with acetazolamide
or Co2 challenge have proven to be suitable methods
in the assessment of CvR [12, 13]. In general, SPECt
is widely used as the standard technique. 15o-PEt has
been  reported  reliable  since  it  provides  information
not only about hemodynamic but also about metabolic
parameters (i.e. oxygen utilization and oxygen extrac-
tion fraction) [14]. However, this procedure is limited
to capacious diagnostic facilities. SPECt with acetazo-
lamide  stress  is  disadvantageous  that  examinations
have to be performed in the course of two days due to
tracer kinetics (a 1-day procedure is generally possible
but is associated with an increase of radiation expo-
sure for the patient as previously described) [15]. fur-
thermore, SPECt can merely provide vague morpho-
logical information compared with PCt or perfusion
MRI [6]. 
PCt studies before and after acetazolamide admin-
istration can be performed on one within 30 minutes.
Ct  images  provide  more  morphological  details  [16,
17]. 
PCt is well established in the diagnostic pathway of
stroke [1]. Recently, this examination has been report-
ed as a predictor for secondary cerebral infarction in
patients  with  subarchnoidal  hemorrhage  (SAH)  [18,
19]. Encouraged by this data we hypothized that PCt
can be used for the assessment of CvR with acetazo-
lamide challenge in an analogous way to SPECt. to
our  knowledge  a  comparative  analysis  of  PCt  and
99mtc-HMPAo SPECt  has  not  been  performed  so
far.  for  the  first  time  we  compared  PCt  data  with
99mtc-HMPAo SPECt  data  in  a  prospective,  non-
randomized setting. 
one limitation of the study is the small number of
patients (n = 13). the second restriction is the SPECt
data acquisition, which was carried out in a semiquan-
titative matter as opposed to the quantitative PCt data
collection.  therefore  the  detailed  PCt  information
had  to  be  reduced  to  obtain  comparable  measure-
ments. A third limitation is the heterogeneous patient
collective. we evaluated patients with Moyamoya dis-
ease as well as patients with ICA occlusion and even
one patient with ICA/MCA occlusion. 
the present study shows a significant difference in
tmax and Mtt measurements on the occluded vs. the
non occluded side in the frontal and parietal region.
the difference in the posterior territories was not sig-
nificant  and  could  be  associated  with  the  tentorial
edge and a less precise representation of the posterior
supratentorial vascular territory in the measurements.
of course it can be also attributed to a lack of steno-
sis in the vertebro-basilar circulation. nonetheless, the
present study shows no clear correlation of PCt and
SPECt regarding the rCbf and rCbv. this can be at-
tributed  to  the  heterogeneous  patient  collective  and
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the small number of patients. However, we found a
considerable  correlation  of  tmax  measurement  and
SPECt  without  a  difference  in  the  subpopulations, 
as opposed to other examinations in which a correla-
tion of Mtt and SPECt was detected [6, 20]. this
could be due to the modified and more precise tmax
[11] data compared to the more frequently used ttP.
According to our examinations, PCt can identify im-
pairment  of  CvR  in  patients  with  symptomatic
carotid  artery  occlusion  in  the  acetazolamide  stress
test  and  corresponds  favorably  to  99mtc-HMPAo
SPECt data. In the present study, tmax data seems to
be a suitable parameter for CvR estimation using the
definitions of delayed tmax as described above (preci-
sion rate of 88.8% to identify patients with preserved
CvR).
Compared  to  SPECt,  PCt  provides  additional
morphological  and  hemodynamic  information.  fur-
thermore it is more readily accessible. Consequently
PCt appears to be an adequate method to identify pa-
tients  with  impaired  CvR  prior  to  bypass  surgery,
However, this remains to be supported by prospective
investigations with a larger patient cohort and quanti-
tative SPECt data.
ConCluSIonS
the  present  non-randomized,  prospective  study
demonstrated  a  highly  significant  correlation  of  the
perfusion  parameters  as  detected  by  99mtc-HMPAo
SPECt and the tmax as detected by PCt in patients
with  ICA  occlusion.  therefore  the  easy-to-perform
PCt examination seems to be an adequate method for
the evaluation of cerebral perfusion in patients with
ICA occlusion.
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